Home
About
Overview
Sharing Data
ORCID
Help
History (63)
Combined-modality therapy for rectal cancer: analysis of potential differences in disease presentation, treatment adherence, and treatment outcome according to race.
Angiotensinogen
Rhythmic intrinsic bursting neurons in human neocortex obtained from pediatric patients with epilepsy.
Opsoclonus-Myoclonus Syndrome
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
See All 63 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology. 2022 05; 162(6):1650-1664.e8.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Arthritis, Psoriatic
Crohn Disease
Double-Blind Method
Humans
Remission Induction
Severity of Illness Index
Treatment Outcome
Ustekinumab
authors with profiles
David Rubin